Skip to main content

Get the latest public health information from CDC

Clinical Info HIV.gov logo
In affiliation with HIV.gov
Main navigation
  • Home
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Mobile Application
  • Resources
  • Contact Us
  • English
  • Español (Spanish)

Language:

  • English
  • Español

clinical info.hiv.gov

Offering Information on HIV/AIDS Treatment, Prevention, and Research

Guidance for Covid-19 and People with HIV is now available.

See Guidance 

Clinical Guidelines

Federally approved medical practice guidelines for HIV/AIDS.
Guidelines 

Drug Database

Information on FDA-approved HIV/AIDS and opportunistic infection drugs and investigational HIV/AIDS drugs. Drugs 

Glossary

Medical dictionary of HIV-related terms.
Glossary 

Resources

HIV-related resources from the National Institutes of Health.
Resources 

Mobile Application

Mobile App Information 
The Clinical Info mobile application gives access to federally approved treatment and research information for HIV and AIDS, optimized for mobile devices free of charge.

Download the beta version of the Clinical Info App for your iOS or Android device.




 

Clinical Info mobile app icon

Download ClinicalInfo Guidelines app on the AppStore
Download ClinicalInfo Guidelines app on GooglePlay

Table 4. Common Drugs Used for Treatment of Opportunistic Infections in HIV-Infected Children: Preparations and Major Toxicities

  • Read more about Table 4. Common Drugs Used for Treatment of Opportunistic Infections in HIV-Infected Children: Preparations and Major Toxicities

Table 3. Treatment

  • Read more about Table 3. Treatment

Table 2. Secondary Prophylaxis

  • Read more about Table 2. Secondary Prophylaxis

Table 1. Primary Prophylaxis

  • Read more about Table 1. Primary Prophylaxis

Appendix 3. Financial Disclosures

  • Read more about Appendix 3. Financial Disclosures

Appendix 2. Panel Members

  • Read more about Appendix 2. Panel Members

Appendix 1. Important Guideline Considerations

  • Read more about Appendix 1. Important Guideline Considerations

Reproductive Options When One or Both Partners Have HIV

  • Read more about Reproductive Options When One or Both Partners Have HIV

Overview

  • Read more about Overview

Table 6. Common or Serious Adverse Reactions Associated with Systemically Administered Drugs Used to Treat Opportunistic Infections

  • Read more about Table 6. Common or Serious Adverse Reactions Associated with Systemically Administered Drugs Used to Treat Opportunistic Infections

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Current page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Next page Next ›
  • Last page Last »

Connect with us

Facebook
Twitter
Instagram
Subscribe

Footer menu

  • Home
  • About
  • Mobile Application
  • News
  • Contact Us
  • Privacy Policy
  • Sponsors
  • Nondiscrimination Notice
  • Disclaimers
  • Accessibility
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.